Back to Journals » OncoTargets and Therapy » Volume 16

Partial Response to Crizotinib in a Lung Adenocarcinoma Patient with a Novel FBXO11 (Intergenic)-ALK (Exon 20-29) Fusion

Total article views   HTML views PDF downloads Totals
2,024 Dovepress* 1,945+ 77 2,022
PubMed Central* 79 37 116
Totals 2,024 114 2,138
*Since 7 July 2023

View citations on PubMed Central and Google Scholar